Skip to main content
TipRanks
Go Ultimate75% OFF

Steven Burrill Insider Profile

4 Followers

Steven Burrill, Director at Gyre Therapeutics, holds 4.33K shares in Gyre Therapeutics (Ticker: GYRE), holds 40.00K shares in Assertio Therapeutics (Ticker: ASRT). Most recently, Steven Burrill Bought ― shares of Gyre Therapeutics on Aug 01, 2012 for an estimated value of $303.31.

Steven Burrill's Trading History

GYRE
Gyre Therapeutics
Aug 01, 2012DirectorInformative Buy303.31$18.68K
ASRT
Assertio Therapeutics
May 13, 2011―Informative Sell1.28M$940.00K

You May Also Like

Steven Burrill insider profile FAQ

What is the percentage of profitable transactions made by Steven Burrill?
The percentage of profitable transactions made by Steven Burrill is 67%.
What is the average return per transaction made by Steven Burrill?
The average return per transaction made by Steven Burrill is 32.90%.
What stocks does Steven Burrill hold?
Steven Burrill holds: GYRE, ASRT stocks.
What was Steven Burrill’s latest transaction?
Steven Burrill’s latest transaction was an Informative Buy of $303.31.
What was Steven Burrill's most profitable transaction?
Steven Burrill’s most profitable transaction was an Informative Sell of GYRE stock on May 12, 2011. The return on the trade was 80.70%.
What is Steven Burrill's role in Gyre Therapeutics?
Steven Burrill's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.